Skip to main content
Siegfried Holding AG logo

Siegfried Holding AG — Investor Relations & Filings

Ticker · SFZN ISIN · CH0014284498 LEI · 506700J9QD6IF3937W06 SW Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2024-12-23 Environmental & Social …
Country CH Switzerland
Listing SW SFZN

About Siegfried Holding AG

https://www.siegfried.ch/?rub=267

Siegfried Holding AG is a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry. The company's core activities involve the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished drug products. Its portfolio of finished dosage forms includes tablets, capsules, sterile vials, and ampoules. Siegfried provides an integrated service model, supporting partners from process development through to commercial-scale production. The company is also expanding its capabilities into specialized areas, including ophthalmic drugs and viral vectors for cell and gene therapies.

Recent filings

Filing Released Lang Actions
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
Environmental & Social Information Classification · 99% confidence The document is explicitly titled 'Media Release' and announces Siegfried's re-inclusion in the Dow Jones Sustainability Index Europe (DJSI). The content focuses entirely on the company's performance regarding environmental, social, and governance (ESG) factors. This directly aligns with the definition for Environmental & Social Information (SR). It is not a full annual report (10-K), an earnings release (ER), or a presentation (IP). Given its specific ESG focus, SR is the most appropriate classification.
2024-12-23 English
Changes in Siegfried's senior management team
Board/Management Information Classification · 100% confidence The document is titled "Changes in Siegfried’s senior management team" and details the appointment of new executives (Chief Scientific Officer, Chief Human Resources Officer, Chief Legal and Sustainability Officer) and the departure of others. This content directly aligns with the definition of Board/Management Information, which covers announcements of changes in senior management. The filing type code for this is MANG.
2024-12-07 English
Changes in Siegfried's senior management team
Board/Management Information Classification · 100% confidence The document is titled "Changes in Siegfried’s senior management team" and details the appointment of new executives (Chief Scientific Officer, Chief Human Resources Officer, Chief Legal and Sustainability Officer) and the departure of others. This content directly aligns with the definition of Board/Management Information, which covers announcements of changes in senior management. The filing type code for this is MANG.
2024-12-06 English
Changes in Siegfried's senior management team
Board/Management Information Classification · 100% confidence The document is explicitly titled a "Media Release" and announces specific personnel changes: the appointment of a new Chief Scientific Officer, Chief Human Resources Officer, and Chief Legal and Sustainability Officer, along with the departure of others. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2024-12-06 English
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
Environmental & Social Information Classification · 99% confidence The document is titled 'News Details' and begins with a date and a headline about Siegfried opening a new R&D Center. It uses terms like 'Media Release' and includes contact information for 'Financial Analysts' and 'Media'. The content describes a corporate event (inauguration of a facility) and strategic updates related to the company's growth ('EVOLVE + strategy'). This format is characteristic of a general corporate announcement or press release, which typically falls under the 'Regulatory Filings' (RNS) category when a more specific financial or statutory filing type (like 10-K, ER, or DIV) is not applicable. It is not a formal financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Given the nature of the announcement (operational expansion), RNS is the most appropriate general regulatory filing category.
2024-11-19 English
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
Regulatory Filings Classification · 100% confidence The document is explicitly titled "Media Release" and announces a specific corporate event: the inauguration of a new R&D Center. It contains key highlights, quotes from the CEO, contact information for media and analysts, and boilerplate 'About Siegfried' information. This format is characteristic of a press release announcing operational news, expansion, or strategic updates, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since there is no specific category for a general corporate announcement/press release that isn't financial results or management change, the most appropriate fallback category is Regulatory Filings (RNS), as these types of announcements are often disseminated via regulatory news services, or it could be considered a general corporate update. Given the options, and since it is not a financial report, management change, or dividend notice, RNS serves as the best fit for a general, time-sensitive corporate announcement disseminated broadly.
2024-11-19 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.